Insider Transactions in Q2 2021 at Better Therapeutics, Inc. (BTTX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
20,000
+27.96%
|
$180,000
$9.95 P/Share
|
|
May 24
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
8,000
+20.23%
|
$72,000
$9.94 P/Share
|
|
May 21
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
8,000
+25.37%
|
$72,000
$9.95 P/Share
|
|
May 14
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
3,060
+16.46%
|
$27,540
$9.93 P/Share
|
|
May 13
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
7,000
+35.94%
|
$63,000
$9.93 P/Share
|
|
May 04
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
3,476
+38.83%
|
$31,284
$9.93 P/Share
|
|
Apr 30
2021
|
David P Perry Executive Chairman |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$18,000
$9.95 P/Share
|
|
Apr 07
2021
|
Dong Liu Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
200,000
-12.71%
|
$1,800,000
$9.0 P/Share
|
|
Apr 07
2021
|
Mountain Crest Capital LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,000
-12.71%
|
$1,800,000
$9.0 P/Share
|
|
Apr 07
2021
|
Suying Liu Director |
SELL
Open market or private sale
|
Indirect |
200,000
-12.71%
|
$1,800,000
$9.0 P/Share
|